Daratumumab, Bortezomib, and Dexamethasone for Treatment of Patients with Relapsed or Refractory Multiple Myeloma and Severe Renal Impairment: Results from the Phase 2 GMMG-DANTE Trial

Leypoldt, Lisa B.; Gavriatopoulou, Maria; Besemer, Britta; Salwender, Hans; Raab, Marc S.; Nogai, Axel; Khandanpour, Cyrus; Runde, Volker; Jauch, Anna; Zago, Manola; Martus, Peter; Goldschmidt, Hartmut; Bokemeyer, Carsten; Dimopoulos, Meletios A.; Weisel, Katja C.

dc.contributor.author	Besemer, Britta
dc.contributor.author	Zago, Manola
dc.contributor.author	Martus, Peter
dc.date.accessioned	2024-06-04T10:27:28Z
dc.date.available	2024-06-04T10:27:28Z
dc.date.issued	2023
dc.identifier.issn	2072-6694
dc.identifier.uri	http://hdl.handle.net/10900/154030
dc.language.iso	en	de_DE
dc.publisher	Basel : Mdpi	de_DE
dc.relation.uri	http://dx.doi.org/10.3390/cancers15184667	de_DE
dc.subject.ddc	610	de_DE
dc.title	Daratumumab, Bortezomib, and Dexamethasone for Treatment of Patients with Relapsed or Refractory Multiple Myeloma and Severe Renal Impairment: Results from the Phase 2 GMMG-DANTE Trial	de_DE
dc.type	Article	de_DE
utue.quellen.id	20240124000000_01369
utue.personen.roh	Leypoldt, Lisa B.
utue.personen.roh	Gavriatopoulou, Maria
utue.personen.roh	Besemer, Britta
utue.personen.roh	Salwender, Hans
utue.personen.roh	Raab, Marc S.
utue.personen.roh	Nogai, Axel
utue.personen.roh	Khandanpour, Cyrus
utue.personen.roh	Runde, Volker
utue.personen.roh	Jauch, Anna
utue.personen.roh	Zago, Manola
utue.personen.roh	Martus, Peter
utue.personen.roh	Goldschmidt, Hartmut
utue.personen.roh	Bokemeyer, Carsten
utue.personen.roh	Dimopoulos, Meletios A.
utue.personen.roh	Weisel, Katja C.
dcterms.isPartOf.ZSTitelID	Cancers	de_DE
dcterms.isPartOf.ZS-Issue	Article 4667	de_DE
dcterms.isPartOf.ZS-Volume	15 (18)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE